Biblio
Donor genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight. Front Immunol. 2024;15:1350470.
Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS Registry. Best Pract Res Clin Haematol. 2024;37(1):101541.
. 5 years DKMS Chile: approach, results and impact of the first unrelated stem cell donor center in Chile. Front Med (Lausanne). 2023;10:1236506.
HLA allele and haplotype frequencies of registered stem cell donors in Chile. Front Immunol. 2023;14:1175135.
. CCR5Δ32 mutations do not determine COVID-19 disease course. Int J Infect Dis. 2021.
. Cryopreservation for all is no option in unrelated stem cell transplantation (Comment to: Dholaria B, et al. Securing the graft during pandemic: are we ready for cryopreservation for all? Biol Blood Marrow Transplant. 2020;26(7):e145-e146.). Biol Blood Marrow Transplant. 2020.
. Immunogenetics in stem cell donor registry work: The DKMS example (Part 2). Int J Immunogenet. 2020.
Introduction of principles of blood management to healthy donor bone marrow harvesting. Vox Sang. 2020.
Non-invasive determination of CMV serostatus from dried buccal swab samples: assay development, validation and application to 1.2 million samples. J Infect Dis. 2020.
. Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS. Bone Marrow Transplant. 2020.
Toward an optimal global stem cell donor recruitment strategy. PLoS One. 2014;9(1):e86605.
. Regional HLA Differences in Poland and Their Effect on Stem Cell Donor Registry Planning. PLoS One. 2013;8(9):e73835.
.